Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-15 Sale |
2023-03-17 6:02 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer |
13,360 | $0.7816 | $10,442 | 265,891 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 7:59 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
13,305 | $1.0697 | $14,232 | 273,251 (Direct) |
View |
| 2022-04-19 Purchase |
2022-04-20 4:35 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
21,925 | $1.14 | $24,994 | 280,556 (Direct) |
View |
| 2021-12-08 Purchase |
2021-12-10 5:26 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
25,000 | $1.91 | $47,750 | 258,631 (Direct) |
View |
| 2020-08-17 Purchase |
2020-08-19 6:48 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Legal Officer |
7,692 | $13 | $99,996 | 10,692 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-25 Option Award |
2025-02-27 4:05 pm |
N/A 2035-02-24 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
91,875 | $0 | 120,864 (Direct) |
View |
| 2024-08-02 Option Award |
2024-08-06 4:09 pm |
N/A 2034-08-01 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
64,394 | $0 | 64,394 (Direct) |
View |
| 2023-10-03 Option Award |
2024-03-12 7:06 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
130,000 | $0 | 130,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:27 pm |
N/A 2034-02-11 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
450,000 | $0 | 450,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:22 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 6:59 pm |
N/A 2032-09-13 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
394,771 | $0 | 394,771 (Direct) |
View |
| 2022-03-08 Option Award |
2022-03-17 4:51 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
255,000 | $0 | 255,000 (Direct) |
View |
| 2021-08-06 Option Award |
2021-08-10 9:24 pm |
N/A 2031-08-05 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section |
380,000 | $0 | 390,692 (Direct) |
View |
| 2021-02-16 Option Award |
2021-02-18 9:05 pm |
N/A 2031-02-15 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Legal Officer |
140,000 | $0 | 140,000 (Direct) |
View |